Insulin Receptor Activation with Transmembrane Domain Ligands
MetadataShow full item record
CitationLee, Jongsoon, Masaya Miyazaki, Giulio R. Romeo, and Steven E. Shoelson. 2014. “Insulin Receptor Activation with Transmembrane Domain Ligands.” Journal of Biological Chemistry 289 (28). American Society for Biochemistry & Molecular Biology (ASBMB): 19769–77. doi:10.1074/jbc.m114.578641.
AbstractComplementary surfaces are buried when peptide hormones, growth factors, or cytokines bind and activate cellular receptors. Although these extended surfaces provide high affinity and specificity to the interactions, they also present great challenges to the design of small molecules that might either mimic or antagonize the process. We show that the insulin receptor (IR) and downstream signals can be activated by targeting a site outside of its ligand-binding domain. A 24-residue peptide having the IR transmembrane (TM) domain sequence activates IR, but not related growth factor receptors, through specific interactions with the receptor TM domain. Like insulin-dependent activation, IR-TM requires that IR have a competent ATP-binding site and kinase activation loop. IR-TM also activates mutated receptors from patients with severe insulin resistance, which do not respond to insulin. These results show that IR can be activated through a pathway that bypasses its canonical ligand-binding domain.
Citable link to this pagehttp://nrs.harvard.edu/urn-3:HUL.InstRepos:41555746
- HMS Scholarly Articles